Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia

Journal of Hematology and Oncology

Volumn 9, Issue 1, 2016, Pages 1-7

  Jin, Zhenyi ^a   Luo, Qiang ^a   Lu, Shuai ^b   Wang, Xinyu ^a   He, Zifan ^a   Lai, Jing ^a,b   Chen, Shaohua ^a   Yang, Lijian ^a   Wu, Xiuli ^a   Li, Yangqiu ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Clonality; T cell receptor; T cells

Indexed keywords

T LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CELL EXPANSION; CELL SELECTION; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FEMALE; GAMMA DELTA T LYMPHOCYTE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOCYTE FUNCTION; MALE; MULTIGENE FAMILY; OLIGOCLONAL EXPANSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRDV1 GENE; TRDV2 GENE; TRDV4 GENE; TRDV8 GENE; ACUTE MYELOID LEUKEMIA; BLOOD CELL; CASE CONTROL STUDY; CELL CLONE; CELL PROLIFERATION; CYTOLOGY; GENETICS; LYMPHOCYTE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS;

BIOMARKERS; BLOOD CELLS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; HUMANS; INTRAEPITHELIAL LYMPHOCYTES; LEUKEMIA, MYELOID, ACUTE; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 84995596457     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-016-0353-3     Document Type: Article

References (35)

1. Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. New Engl J Med. 2015;373(12):1136-52.
2. Lu S, Wang J. Homoharringtonine and omacetaxine for myeloid hematological malignancies. J Hematol Oncol. 2014;7:2.
3. Loghavi S, Zuo Z, Ravandi F, Kantarjian HM, Bueso-Ramos C, Zhang L, et al. Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations. J Hematol Oncol. 2014;7:74.
4. Cheng HH, Soleau C, Yu EY. Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy. J Hematol Oncol. 2015;8:51.
5. Chen S, Zha X, Shi L, Zhou L, Yang L, Li B, et al. Upregulated TCR zeta improves cytokine secretion in T cells from patients with AML. J Hematol Oncol. 2015;8:72.
6. Xu L, Zhang Y, Luo G, Li Y. The roles of stem cell memory T cells in hematological malignancies. J Hematol Oncol. 2015;8:113.
7. Vantourout P, Hayday A. Six-of-the-best: unique contributions of gamma delta T cells to immunology. Nat Rev Immunol. 2013;13(2):88-100.
8. Paul S, Lal G. Regulatory and effector functions of gamma-delta (gamma delta) T cells and their therapeutic potential in adoptive cellular therapy for cancer. Int J Cancer. 2016;139(5):976-85.
9. Saito A, Narita M, Watanabe N, Tochiki N, Satoh N, Yano T, et al. Anti-tumor cytotoxicity of gamma delta T cells expanded from blood cells of myeloma and leukemia patients against self tumor cells - enhancement of the anti-tumor cytotoxicity by type IIFN, dendritic cells, and activated alpha beta T cells. Blood. 2007;110(11):264b.
10. Lafont V, Sanchez F, Laprevotte E, Michaud HA, Gros L, Eliaou JF, et al. Plasticity of gamma delta T cells: impact on the anti-tumor response. Front Immunol. 2014;5:662.
11. Braza MS, Klein B. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. Br J Haematol. 2013;160(2):123-32.
12. Mariani S, Muraro M, Pantaleoni F, Fiore F, Nuschak B, Peola S, et al. Effector gamma delta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia. 2005;19(4):664-70.
13. Burjanadze M, Condomines M, Reme T, Quittet P, Latry P, Lugagne C, et al. In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma. Br J Haematol. 2007;139(2):206-16.
14. D'Asaro M, La Mendola C, Di Liberto D, Orlando V, Todaro M, Spina M, et al. V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. J Immunol. 2010;184(6):3260-8.
15. Kiladjian JJ, Visentin G, Vieyl E, Chevret S, Eclache V, Stirnemann J, et al. Activation of cytotoxic T-cell receptor gamma delta T lymphocytes in response to specific stimulation in myelodysplastic syndromes. Haematol-Hematol J. 2008;93(3):381-9.
16. Groh V, Porcelli S, Fabbi M, Lanier LL, Picker LJ, Anderson T, et al. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med. 1989;169(4):1277-94.
17. Born WK, Aydintug MK, O'Brien RL. Diversity of gamma delta T-cell antigens. Cell Mol Immunol. 2013;10(1):13-20.
18. Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Wevers E, et al. Tumor-infiltrating gamma delta T lymphocytes predict clinical outcome in human breast cancer. J Immunol. 2012;189(10):5029-36.
19. Xu L, Weng J, Huang X, Zeng C, Chen S, Geng S, et al. Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI. Oncotarget. 2016;7(28):42943-52.
20. Zhang X, Chen S, Yang L, Li B, Zhu K, Li Y. The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura. Hematology. 2009;14(4):237-44.
21. Xuan L, Wu X, Zhang Y, Fan Z, Ling Y, Huang F, et al. Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease. J Transl Med. 2011;9(1):1.
22. Geng S, Weng J, Du X, Lai P, Huang X, Chen S, et al. Comparison of the distribution and clonal expansion features of the T-cell gamma delta repertoire in myelodysplastic syndrome-RAEB and RAEB with progression to AML. DNA Cell Biol. 2012;31(10):1563-70.
23. Wang L, Xu M, Wang C, Zhu L, Hu J, Chen SH, et al. The feature of distribution and clonality of TCR gamma/delta subfamilies T cells in patients with B-cell non-Hodgkin lymphoma. J Immunol Res. 2014;2014:241246.
24. Bartkowiak J, Kulczycka-Wojdala D, Blonski JZ, Robak T. Molecular diversity of gamma delta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia. Neoplasma. 2002;49(2):86-90.
25. Yang Q, Li P, Li Y, Wu X, Huang X, Chen Y, et al. Effects of immunotherapy on the distribution and clonality of TCR V gamma and V delta subfamily T cells in allergic rhinitis patients. J Med Biochem. 2012;31(2):94-9.
26. Meeh PF, King M, O'Brien RL, Muga S, Buckhalts P, Neuberg R, et al. Characterization of the γδ T cell response to acute leukemia. Cancer Immunol Immunother. 2006;55(9):1072-80.
27. Siegers GM, Felizardo TC, Mathieson AM, Kosaka Y, Wang XH, Medin JA, et al. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph + leukemia model. Plos ONE. 2011;6(2):e16700.
28. Zarin P, Chen ELY, In TSH, Anderson MK, Zuniga-Pflucker JC. Gamma delta T-cell differentiation and effector function programming, TCR signal strength, when and how much? Cell Immunol. 2015;296(1):70-5.
29. Chen S, Huang X, Zheng H, Geng S, Wu X, Yang L, et al. The evolution of malignant and reactive gamma delta plus T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation. Mol Cancer. 2013;12(1):1.
30. Li Y, Geng S, Du X, Chen S, Yang L, Wu X, et al. Restricted TRBV repertoire in CD4(+) and CD8(+) T-cell subsets from CML patients. Hematology. 2011;16(1):43-9.
31. Li B, Li Y, Chen S, Yang L, Yu W, Chen J, et al. The T-cell receptor V beta gene repertoire and clonal expansion from peripheral blood T cells in benzene-exposed workers in China. Hematology. 2009;14(2):106-10.
32. Jin Z, Wu X, Chen S, Yang L, Liu Q, Li Y. Distribution and clonality of the V alpha and V beta T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease. DNA Cell Biol. 2014;33(3):182-8.
33. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol. 1994;153(6):2807-18.
34. Li Y, Chen S, Yang L, Yin Q, Geng S, Wu X, et al. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transpl Immunol. 2007;18(2):151-8.
35. Li Y, Chen S, Yang L, Li B, Chan J, Cai D. TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood. Transpl Immunol. 2009;20(3):155-62.